Open AccessTofacitinib for Prurigo Nodularis: A Case Report
Author(s) -
Changlan Peng,
Chunxiao Li,
Yingying Zhou,
Qiuyue Wang,
Ping Xie,
Tianhao Li,
Pingsheng Hao
Publication year - 2022
Publication title -
clinical, cosmetic and investigational dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.73
H-Index - 35
ISSN - 1178-7015
DOI - 10.2147/ccid.s354025
Subject(s) - prurigo nodularis , medicine , tofacitinib , janus kinase inhibitor , dermatology , prurigo , dupilumab , symptom relief , atopic dermatitis , surgery , rheumatoid arthritis
Despite recent advances in the treatment of prurigo nodularis, conventional treatment suffers from a dilemma of poor efficacy. The clinical use of Janus kinase (JAK) inhibitors in the treatment of Prurigo nodularis has rarely been explored.